Publication
Article
Pharmaceutical Technology
Pharmaceutical Technology-06-01-2005Volume205 Supplement Issue 3
The Part 11 Controversy: A Root Cause Analysis and Science-Based Solutions
The confusion surrounding the application of 21 CFR Part 11 can be solved by focusing on the common rationale that both protects the public health and drives the fundamental basis of the industry's business: good science.
Articles in this issue
Electronic Records Management Practices and Part 11
Applying Part 11 to the Implementation of Quality Management Software
Glossary of terms
The Part 11 Controversy A Root Cause Analysis and Science-Based Solutions Gordon B. Richman
The Part 11 Controversy: A Root Cause Analysis and Science-Based Solutions
Applying Part 11 to the Implementation of Quality Management Software Chet Shemanski and Gregg F. Clyne
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Videos
Related Content
